Drugs / rAAV9-CB6-AspA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05317780 | — | Canavan disease | University of Florida | No longer available | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rAAV9-CB6-AspA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05317780 ↗ |
| Route | Intravenous | “single intravenous (IV) and intracerebroventricular (ICV) administration of rAAV9-CB6-AspA” NCT05317780 ↗ |
| Route | Other | “single intravenous (IV) and intracerebroventricular (ICV) administration of rAAV9-CB6-AspA” NCT05317780 ↗ |